RxDoctor Payments Data

Shannon Trammell

Physician Assistant · Corvallis, ORNPI 1679129753

Payments from drug & device makers

$2,313in general payments, 2019–2025

Across 50 payments — averaging $46.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Livanova USA, Inc.$786
  • AbbVie$331
  • AstraZeneca$312
  • Novo Nordisk$121
  • Bayer$111
  • Lilly USA, LLC$109
  • plus $544 from 10 others

What the payments were for

  • Travel & lodging$27012%
  • Food & beverage$2,04388%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,313 in reported general payments places this provider in the 90th percentile of 1,756 physician assistant providers in Oregon.

See all physician assistant providers in Oregon

Medicare billing

Part B allowed, 2024
$15,160
Medicare patients
89
Services billed
275

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban19$15,505
Alendronate Sodium24$2,299
Gabapentin64$1,106
Albuterol Sulfate HfaAlbuterol Sulfate29$736
Tizanidine Hcl38$609
Losartan Potassium32$602
Pravastatin Sodium35$593
Atorvastatin Calcium47$437
Levothyroxine Sodium34$434
Montelukast Sodium26$432
Lisinopril42$353
Trazodone Hcl41$266
Amlodipine Besylate35$171
Tamsulosin Hcl11$148
Famotidine15$143

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$67$15,50519 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,756 physician assistant providers in Oregon.

Other physician assistant in Corvallis

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →